0001565847-14-000003.txt : 20140926 0001565847-14-000003.hdr.sgml : 20140926 20140926113752 ACCESSION NUMBER: 0001565847-14-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20140926 DATE AS OF CHANGE: 20140926 EFFECTIVENESS DATE: 20140926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Benson Hill Biosystems, Inc. CENTRAL INDEX KEY: 0001565847 IRS NUMBER: 455483749 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-215469 FILM NUMBER: 141123018 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD, SUITE 250 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-741-7113 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD, SUITE 250 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 D/A 1 primary_doc.xml X0707 D/A LIVE 0001565847 Benson Hill Biosystems, Inc. 7020 KIT CREEK ROAD, SUITE 250 RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 919-741-7113 NORTH CAROLINA None None Corporation true 2012 Matthew B Crisp 440 WEYCROFT GRANT DRIVE Cary NC NORTH CAROLINA 27519 Executive Officer Director Daniel J Broderick 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Director Gregg Bogosian 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Director Bruce A Jamerson 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Director Walter P Siggelko 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Director Thomas P Brutnell 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Todd C Mockler 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Lee Palles 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Nadine Carozzi 7020 Kit Creek Road, Suite 250 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Other Technology Decline to Disclose 06c true 0001565847-14-000001 2014-04-04 false true true true true false 40000 1000000 800000 200000 false 4 0 0 0 true The proceeds of this offering of Unsecured Convertible Promissory Notes will be used for working capital leading up to the closing of a planned sale of Series A Preferred stock. A portion of the working capital may be used to fund employee salaries. false Benson Hill Biosystems, Inc. Matthew B. Crisp Matthew B Crisp President 2014-09-26